Simon Sturge insider trades
Open-market stock purchases and sales by Simon Sturge, Director at MoonLake Immunotherapeutics, from SEC Form 4 filings since Apr 6, 2022.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- MLTX MoonLake Immunotherapeutics: 1 sale, last Jun 5, 2025